• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

癌症恶病质的进行性、多器官和多层次性质。

Progressive, multi-organ, and multi-layered nature of cancer cachexia.

机构信息

Inter-Organ Communication Research Team, Institute for Life and Medical Sciences, Kyoto, Japan.

Department of Breast Surgery, Kyoto University Graduate School of Medicine, Kyoto, Japan.

出版信息

Cancer Sci. 2024 Mar;115(3):715-722. doi: 10.1111/cas.16078. Epub 2024 Jan 22.

DOI:10.1111/cas.16078
PMID:38254286
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10921013/
Abstract

Cancer cachexia is a complex, multifaceted condition that negatively impacts the health, treatment efficacy, and economic status of cancer patients. The management of cancer cachexia is an essential clinical need. Cancer cachexia is currently defined mainly according to the severity of weight loss and sarcopenia (i.e., macrosymptoms). However, such macrosymptoms may be insufficient to give clinicians clues on how to manage this condition as these symptoms appear at the late stage of cancer. We need to understand earlier events during the progression of cancer cachexia so as not to miss a clinical opportunity to control this complex syndrome. Recent research indicates that cancer-induced changes in the host are much wider than previously recognized, including disruption of liver function and the immune system. Furthermore, such changes are observed before the occurrence of visible distant metastases (i.e., in early, localized cancers). In light of these findings, we propose to expand the definition of cancer cachexia to include all cancer-induced changes to host physiology, including changes caused by early, localized cancers. This new definition of cancer cachexia can provide a new perspective on this topic, which can stimulate the research and development of novel cancer cachexia therapies.

摘要

癌症恶病质是一种复杂的、多方面的疾病,会对癌症患者的健康、治疗效果和经济状况产生负面影响。癌症恶病质的管理是一种重要的临床需求。癌症恶病质目前主要根据体重减轻和肌肉减少症(即宏观症状)的严重程度来定义。然而,这些宏观症状可能不足以提示临床医生如何管理这种情况,因为这些症状出现在癌症的晚期。我们需要了解癌症恶病质进展过程中的早期事件,以免错过控制这种复杂综合征的临床机会。最近的研究表明,癌症对宿主的影响比以前认识的要广泛得多,包括肝功能和免疫系统的破坏。此外,这些变化在可见的远处转移发生之前就已经出现(即在早期的局部癌症中)。有鉴于此,我们建议将癌症恶病质的定义扩大到包括宿主生理学的所有由癌症引起的变化,包括早期局部癌症引起的变化。这种癌症恶病质的新定义可以为这一主题提供一个新的视角,从而激发对新型癌症恶病质治疗方法的研究和开发。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/83b9/10921013/c4447fa14033/CAS-115-715-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/83b9/10921013/92ebac5c5e48/CAS-115-715-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/83b9/10921013/e0ac4ef8de1d/CAS-115-715-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/83b9/10921013/311e38c113ad/CAS-115-715-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/83b9/10921013/c4447fa14033/CAS-115-715-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/83b9/10921013/92ebac5c5e48/CAS-115-715-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/83b9/10921013/e0ac4ef8de1d/CAS-115-715-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/83b9/10921013/311e38c113ad/CAS-115-715-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/83b9/10921013/c4447fa14033/CAS-115-715-g001.jpg

相似文献

1
Progressive, multi-organ, and multi-layered nature of cancer cachexia.癌症恶病质的进行性、多器官和多层次性质。
Cancer Sci. 2024 Mar;115(3):715-722. doi: 10.1111/cas.16078. Epub 2024 Jan 22.
2
Definition and classification of cancer cachexia: an international consensus.癌症恶病质的定义和分类:国际共识。
Lancet Oncol. 2011 May;12(5):489-95. doi: 10.1016/S1470-2045(10)70218-7. Epub 2011 Feb 4.
3
Measuring cachexia-diagnostic criteria.测量恶病质诊断标准。
Ann Palliat Med. 2019 Jan;8(1):24-32. doi: 10.21037/apm.2018.08.07. Epub 2018 Sep 7.
4
Malnutrition, sarcopenia, and cancer cachexia in gynecologic cancer.妇科癌症中的营养不良、肌肉减少症和癌症恶病质
Gynecol Oncol. 2023 Aug;175:142-155. doi: 10.1016/j.ygyno.2023.06.015. Epub 2023 Jun 27.
5
Cancer cachexia in thoracic malignancy: a narrative review.胸部恶性肿瘤中的癌症恶病质:一篇综述
Curr Opin Support Palliat Care. 2019 Dec;13(4):316-322. doi: 10.1097/SPC.0000000000000465.
6
Influence of cachexia and sarcopenia on survival in pancreatic ductal adenocarcinoma: a systematic review.恶病质和肌肉减少症对胰腺导管腺癌患者生存的影响:一项系统评价
Pancreatology. 2015 Jan-Feb;15(1):19-24. doi: 10.1016/j.pan.2014.11.006. Epub 2014 Dec 4.
7
Sarcopenia, Malnutrition, and Cachexia: Adapting Definitions and Terminology of Nutritional Disorders in Older People with Cancer.肌肉减少症、营养不良和恶病质:癌症老年患者营养障碍定义和术语的调整。
Nutrients. 2021 Feb 26;13(3):761. doi: 10.3390/nu13030761.
8
Cancer Cachexia: One Step Ahead.癌症恶病质:更进一步
Rev Recent Clin Trials. 2015;10(3):246-50. doi: 10.2174/1574887110666150916141351.
9
Cachexia and sarcopenia: mechanisms and potential targets for intervention.恶病质与肌肉减少症:发病机制及潜在干预靶点
Curr Opin Pharmacol. 2015 Jun;22:100-6. doi: 10.1016/j.coph.2015.04.003. Epub 2015 May 14.
10
For an operational definition of cachexia.关于恶病质的操作性定义。
Lancet Oncol. 2011 May;12(5):423-4. doi: 10.1016/S1470-2045(11)70113-9.

引用本文的文献

1
Intra-Tumoral Lymphocytic Infiltration Is Associated with Favorable Prognosis in Suboptimal Surgery in High-Grade Serous Ovarian Carcinoma.肿瘤内淋巴细胞浸润与高级别浆液性卵巢癌次优手术患者的良好预后相关。
Diagnostics (Basel). 2025 Feb 10;15(4):422. doi: 10.3390/diagnostics15040422.
2
Convergent inducers and effectors of T cell paralysis in the tumour microenvironment.肿瘤微环境中T细胞麻痹的趋同诱导因子和效应因子。
Nat Rev Cancer. 2025 Jan;25(1):41-58. doi: 10.1038/s41568-024-00761-z. Epub 2024 Oct 24.

本文引用的文献

1
Decreased liver B vitamin-related enzymes as a metabolic hallmark of cancer cachexia.癌症恶病质的代谢特征:肝脏 B 族维生素相关酶活性降低。
Nat Commun. 2023 Oct 6;14(1):6246. doi: 10.1038/s41467-023-41952-w.
2
Current Therapeutic Targets in Cancer Cachexia: A Pathophysiologic Approach.癌症恶病质的当前治疗靶点:病理生理学方法。
Am Soc Clin Oncol Educ Book. 2023 Jun;43:e389942. doi: 10.1200/EDBK_389942.
3
Oncogenic stress-induced Netrin is a humoral signaling molecule that reprograms systemic metabolism in Drosophila.致癌应激诱导的神经导向因子 Netrin 是一种体液信号分子,可重塑果蝇的全身代谢。
EMBO J. 2023 Jun 15;42(12):e111383. doi: 10.15252/embj.2022111383. Epub 2023 May 4.
4
NAD repletion with niacin counteracts cancer cachexia.烟酰胺腺嘌呤二核苷酸(NAD)的补充可以对抗癌症恶病质。
Nat Commun. 2023 Apr 3;14(1):1849. doi: 10.1038/s41467-023-37595-6.
5
Serum amyloid alpha 1-2 are not required for liver inflammation in the 4T1 murine breast cancer model.血清淀粉样蛋白 α1-2 对于 4T1 鼠乳腺癌模型中的肝脏炎症并非必需。
Front Immunol. 2023 Feb 3;14:1097788. doi: 10.3389/fimmu.2023.1097788. eCollection 2023.
6
Murine breast cancers disorganize the liver transcriptome in a zonated manner.鼠类乳腺癌以区域性方式扰乱肝脏转录组。
Commun Biol. 2023 Jan 24;6(1):97. doi: 10.1038/s42003-023-04479-w.
7
Remote solid cancers rewire hepatic nitrogen metabolism via host nicotinamide-N-methyltransferase.远程实体瘤通过宿主烟酰胺-N-甲基转移酶重编肝脏氮代谢。
Nat Commun. 2022 Jun 15;13(1):3346. doi: 10.1038/s41467-022-30926-z.
8
Cancer cachexia as a determinant of efficacy of first-line pembrolizumab in patients with advanced non-small cell lung cancer.癌症恶病质作为晚期非小细胞肺癌患者一线帕博利珠单抗疗效的决定因素。
Mol Clin Oncol. 2022 Apr;16(4):91. doi: 10.3892/mco.2022.2524. Epub 2022 Feb 24.
9
Iron supplementation is sufficient to rescue skeletal muscle mass and function in cancer cachexia.铁补充剂足以挽救癌症恶病质患者的骨骼肌质量和功能。
EMBO Rep. 2022 Apr 5;23(4):e53746. doi: 10.15252/embr.202153746. Epub 2022 Feb 24.
10
Coordination of tumor growth and host wasting by tumor-derived Upd3.肿瘤衍生 Upd3 协调肿瘤生长和宿主消耗
Cell Rep. 2021 Aug 17;36(7):109553. doi: 10.1016/j.celrep.2021.109553.